Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
2021 · Nature Communications · 561 citations
https://doi.org/10.1038/s41467-021-21099-2
Y
Yalan Deng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
83
Papers
2.6K
Citations
25
h-index
39
i10-index
Yalan Deng is an academic researcher from Central South University. The author has contributed to research in topics: Oral microbiology and periodontitis research & Cancer-related molecular mechanisms research & Crystal Structures and Properties. The author has an h-index of 25, co-authored 71 publications.
ORCID: 0000-0002-3954-3243Papers by this author
worksA targetable LIFR−NF-κB−LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis
2021 · Nature Communications · 329 citations
https://doi.org/10.1038/s41467-021-27452-9
Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance
2021 · Nature Communications · 140 citations
https://doi.org/10.1038/s41467-021-27349-7
Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer
2022 · Cell Death Discovery · 109 citations
https://doi.org/10.1038/s41420-022-01101-6
Non-canonical function of DGCR8 in DNA double-strand break repair signaling and tumor radioresistance
2021 · Nature Communications · 70 citations
https://doi.org/10.1038/s41467-021-24298-z
Computational repositioning of dimethyl fumarate for treating alcoholic liver disease
2020 · Cell Death and Disease · 55 citations
https://doi.org/10.1038/s41419-020-02890-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat